Primary tabs
The list of publications is indicative and may not include all publications.
Safety and Efficacy of Eltrombopag in Children and Adults with Immune Thrombocytopenia: a Systematic Review and Meta-analysis.:.
Cardiovascular & Hematological Agents in Medicinal Chemistry. 18,
(2020).
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality..
Ann Hematol. 98(1), 55-66.
(2019).
Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α/αα Thalassemia Deletion in Greece: Clinical Phenotype and Genetic Counseling..
Hemoglobin. 42(2), 129-131.
(2018).
A 2-year prospective densitometric study on the influence of Fok-I gene polymorphism in young patients with thalassaemia major..
Osteoporos Int. 27(2), 781-8.
(2016).
Association between iron deficiency and febrile seizures..
Eur J Paediatr Neurol. 19(5), 591-6.
(2015).
Multiple endocrine disorders associated with adrenomyeloneuropathy and a novel mutation of the ABCD1 gene..
Pediatr Neurol. 50(6), 622-4.
(2014).
Successful management of a small infant with Kasabach-Merritt phenomenon using vincristine: a case report..
Blood Coagul Fibrinolysis. 25(7), 777-9.
(2014).
Laboratory investigation of platelet function in patients with thalassaemia..
Acta Haematol. 132(1), 45-8.
(2014).
Combined chelation therapy with deferoxamine and deferiprone in β-thalassemia major: compliance and opinions of young thalassemic patients..
Hemoglobin. 38(2), 111-4.
(2014).
FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia: implications for disease pathogenesis and outcome..
Blood Coagul Fibrinolysis. 24(1), 35-9.
(2013).
Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin..
Blood Coagul Fibrinolysis. 23(3), 195-202.
(2012).
Restrictive pulmonary dysfunction and its predictors in young patients with β-thalassaemia major..
Pediatr Pulmonol. 47(8), 801-7.
(2012).
Fok-I gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status..
Hematology. 16(1), 54-8.
(2011).
Use of propranolol in infantile haemangiomas: report of five cases and review of the literature..
Hippokratia. 15(1), 81-3.
(2011).
Fok-I polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major..
Pediatr Hematol Oncol. 28(6), 509-16.
(2011).
Elevated serum parathormone levels are associated with myocardial iron overload in patients with beta-thalassaemia major..
Eur J Haematol. 84(1), 64-71.
(2010).
Increased osteoclastic activity as shown by increased sRANK-L/OPG ratio in boys with hemophilia..
Ann Hematol. 89(8), 837-8.
(2010).
Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox..
Acta Haematol. 123(3), 148-52.
(2010).
Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa..
Blood Coagul Fibrinolysis. 21(6), 611-3.
(2010).
Successful treatment of a spontaneous haemothorax with recombinant factor VIIa in a haemophilic child with inhibitors..
Hippokratia. 14(4), 289-90.
(2010).
MRI assessment of liver iron content in thalassamic patients with three different protocols: comparisons and correlations..
Eur J Haematol. 82(5), 388-92.
(2009).